UroGen Pharma (URGN): TD Bank group discloses 3.37M shares, 6.9% beneficial stake

The Toronto-Dominion Bank and TD Securities Inc. have jointly reported beneficial ownership of 3,371,263 ordinary shares of UroGen Pharma Ltd. This represents a 6.9% stake in the company. The filing specifies the individual voting and dispositive powers of both TD Bank and TD Securities over these shares, clarifying that TD Bank disclaims beneficial ownership of TD Securities' shares except for its pecuniary interest.